Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

"Salvage Use" of Recombinant Activated Factor VII After Inadequate Haemostatic Response to Conventional Therapy in Complex Cardiac Surgery - a Randomised Placebo Controlled Trial

NCT00214656 is registered in ClinicalTrials.gov with Austin Health as lead sponsor.

NCT NCT00214656
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00214656 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
"Salvage Use" of Recombinant Activated Factor VII After Inadequate Haemostatic Response to Conventional Therapy in Complex Cardiac Surgery - a Randomised Placebo Controlled Trial
Lead sponsor
Austin Health
Phase
Phase 3
Overall status
Unknown status
Start date
June 30, 2005
Completion date
June 30, 2008
Enrollment
40
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

blood coagulation disorders, coronary artery disease, heart valve diseases, myocardial ischemia